Kurt R. Zinn - Publications

Affiliations: 
Pathology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Molecular Biology

102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gentile CM, Borovjagin AV, Richter JR, Jani AH, Wu H, Zinn KR, Warram JM. Genetic strategy to decrease complement activation with adenoviral therapies. Plos One. 14: e0215226. PMID 31026285 DOI: 10.1371/journal.pone.0215226  0.44
2017 Rosenthal E, Moore L, Tipirneni K, de Boer E, Stevens TM, Hartman YE, Carroll WR, Zinn KR, Warram JM. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28446503 DOI: 10.1158/1078-0432.CCR-16-2968  0.44
2016 Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, Wapnir IL, Liao JC, Bouvet M, Behnke NK, Hawn MT, Poultsides GA, Vahrmeijer AL, Carroll WR, Zinn KR, et al. Oncologic Procedures Amenable to Fluorescence-guided Surgery. Annals of Surgery. PMID 28045715 DOI: 10.1097/SLA.0000000000002127  0.44
2016 Moore LS, Rosenthal EL, de Boer E, Prince AC, Patel N, Richman JM, Morlandt AB, Carroll WR, Zinn KR, Warram JM. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27830425 DOI: 10.1007/s11307-016-1022-1  0.44
2016 Moore LS, Rosenthal EL, Chung TK, de Boer E, Patel N, Prince AC, Korb ML, Walsh EM, Young ES, Stevens TM, Withrow KP, Morlandt AB, Richman J, Carroll WR, Zinn KR, et al. Characterizing the utilities and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587708 DOI: 10.2967/jnumed.115.171413  0.44
2016 Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, Korf BR, Kesterson RA. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Disease Models & Mechanisms. 9: 759-767. PMID 27482814 DOI: 10.1242/dmm.025783  0.44
2016 Vaklavas C, Grizzle WE, Choi H, Meng Z, Zinn KR, Shrestha K, Blume SW. IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27460074 DOI: 10.1007/s13277-016-5161-4  0.44
2016 Kasten BB, Azure MT, Schoeb TR, Fisher DR, Zinn KR. Imaging, biodistribution, and toxicology evaluation of (212)Pb-TCMC-trastuzumab in nonhuman primates. Nuclear Medicine and Biology. 43: 391-396. PMID 27179247 DOI: 10.1016/j.nucmedbio.2016.04.001  0.44
2016 Liu Y, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ. GHR/PRLR Hetero-multimer is Composed of GHR Homodimers and PRLR Homodimers. Molecular Endocrinology (Baltimore, Md.). me20151319. PMID 27003442 DOI: 10.1210/me.2015-1319  0.44
2015 Kim H, Buchsbaum DJ, Zinn KR. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26552657 DOI: 10.1007/s11307-015-0913-x  0.44
2015 Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, Bouvet M, Brigman BE, Colson YL, DeMeester SR, Gurtner GC, Ishizawa T, Jacobs PM, Keereweer S, Liao JC, ... ... Zinn KR, et al. Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26449839 DOI: 10.2967/jnumed.115.158915  0.44
2015 de Boer E, Samuel S, French DN, Warram JM, Schoeb TR, Rosenthal EL, Zinn KR. Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26335283 DOI: 10.1007/s11307-015-0892-y  0.44
2015 Vaklavas C, Meng Z, Choi H, Grizzle WE, Zinn KR, Blume SW. Small molecule inhibitors of IRES-mediated translation. Cancer Biology & Therapy. 0. PMID 26177060 DOI: 10.1080/15384047.2015.1071729  0.44
2015 de Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, de Jong JS, Chung TK, Korb ML, Zinn KR, van Dam GM, Rosenthal EL, Brandwein-Gensler MS. In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas. Scientific Reports. 5: 10169. PMID 26120042 DOI: 10.1038/srep10169  0.44
2015 Rosenthal EL, Warram JM, de Boer E, Chung TK, Korb ML, Brandwein-Gensler M, Strong TV, Schmalbach C, Morlandt A, Agarwal G, Hartman YE, Carroll W, Richman JS, Clemons L, Nabell LM, ... Zinn KR, et al. Safety and Tumor-specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25904751 DOI: 10.1158/1078-0432.CCR-14-3284  0.44
2015 Kim H, Cam-Etoz B, Zhai G, Hubbard WJ, Zinn KR, Chaudry IH. Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury. Journal of Neurotrauma. PMID 25646701 DOI: 10.1089/neu.2014.3771  0.44
2015 Rosenthal EL, Warram JM, Bland KI, Zinn KR. The status of contemporary image-guided modalities in oncologic surgery. Annals of Surgery. 261: 46-55. PMID 25599326 DOI: 10.1097/SLA.0000000000000622  0.44
2015 Zinn KR, Korb M, Samuel S, Warram JM, Dion D, Killingsworth C, Fan J, Schoeb T, Strong TV, Rosenthal EL. IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 49-57. PMID 25080323 DOI: 10.1007/s11307-014-0773-9  0.44
2014 Bhattacharyya S, Patel N, Wei L, Riffle LA, Kalen JD, Hill GC, Jacobs PM, Zinn KR, Rosenthal E. Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers. Medchemcomm. 5: 1337-1346. PMID 25431648 DOI: 10.1039/C4MD00116H  0.44
2014 Nelson CA, Azure MT, Adams CT, Zinn KR. The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenografts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 2020-5. PMID 25359879 DOI: 10.2967/jnumed.114.140780  0.44
2014 Gan Y, Buckels A, Liu Y, Zhang Y, Paterson AJ, Jiang J, Zinn KR, Frank SJ. Human GH receptor-IGF-1 receptor interaction: implications for GH signaling. Molecular Endocrinology (Baltimore, Md.). 28: 1841-54. PMID 25211187 DOI: 10.1210/me.2014-1174  0.44
2014 Liu Y, Berry PA, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ. Dynamic analysis of GH receptor conformational changes by split luciferase complementation. Molecular Endocrinology (Baltimore, Md.). 28: 1807-19. PMID 25188449 DOI: 10.1210/me.2014-1153  0.44
2014 Kim H, Samuel SL, Zhai G, Rana S, Taylor M, Umphrey HR, Oelschlager DK, Buchsbaum DJ, Zinn KR. Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer. Cancer Biology & Therapy. 15: 1053-60. PMID 25084100 DOI: 10.4161/cbt.29183  0.44
2014 Richter JR, Mahoney M, Warram JM, Samuel S, Zinn KR. A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging. Gene Therapy. 21: 897-902. PMID 25056609 DOI: 10.1038/gt.2014.68  0.44
2014 Warram JM, Sorace AG, Mahoney M, Samuel S, Harbin B, Joshi M, Martin A, Whitworth L, Hoyt K, Zinn KR. Biodistribution of P-selectin targeted microbubbles. Journal of Drug Targeting. 22: 387-94. PMID 24731055 DOI: 10.3109/1061186X.2013.869822  0.44
2014 Sorace AG, Korb M, Warram JM, Umphrey H, Zinn KR, Rosenthal E, Hoyt K. Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer. Ultrasound in Medicine & Biology. 40: 755-64. PMID 24412168 DOI: 10.1016/j.ultrasmedbio.2013.11.002  0.44
2014 Korb ML, Hartman YE, Kovar J, Zinn KR, Bland KI, Rosenthal EL. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer. The Journal of Surgical Research. 188: 119-28. PMID 24360117 DOI: 10.1016/j.jss.2013.11.1089  0.44
2014 Zhai G, Kim H, Sarver D, Samuel S, Whitworth L, Umphrey H, Oelschlager DK, Beasley TM, Zinn KR. Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy. Journal of Magnetic Resonance Imaging : Jmri. 39: 1588-94. PMID 24151215 DOI: 10.1002/jmri.24319  0.44
2014 Kim H, Rigell CJ, Zhai G, Lee SK, Samuel SL, Martin A, Umphrey HR, Stockard CR, Beasley TM, Buchsbaum DJ, Li LS, Boothman DA, Zinn KR. Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 85-94. PMID 23836505 DOI: 10.1007/s11307-013-0665-4  0.44
2013 Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K. Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. Ultrasound in Medicine & Biology. 39: 2374-81. PMID 24063960 DOI: 10.1016/j.ultrasmedbio.2013.07.017  0.44
2013 Sweeny L, Hartman YE, Zinn KR, Prudent JR, Marshall DJ, Shekhani MS, Rosenthal EL. A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. Oral Oncology. 49: 991-7. PMID 23920309 DOI: 10.1016/j.oraloncology.2013.07.006  0.44
2013 Rosenthal EL, Zinn KR. Putting numbers to fluorescent guided surgery. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 647-8. PMID 23836503 DOI: 10.1007/s11307-013-0662-7  0.44
2013 Day KE, Sweeny L, Kulbersh B, Zinn KR, Rosenthal EL. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 722-9. PMID 23715932 DOI: 10.1007/s11307-013-0652-9  0.44
2013 Day KE, Beck LN, Deep NL, Kovar J, Zinn KR, Rosenthal EL. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. The Laryngoscope. 123: 2681-9. PMID 23616260 DOI: 10.1002/lary.24102  0.44
2013 Heath CH, Deep NL, Beck LN, Day KE, Sweeny L, Zinn KR, Huang CC, Rosenthal EL. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 148: 982-90. PMID 23525846 DOI: 10.1177/0194599813482290  0.44
2013 Sorace AG, Saini R, Rosenthal E, Warram JM, Zinn KR, Hoyt K. Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 60: 281-9. PMID 23357902 DOI: 10.1109/TUFFC.2013.2564  0.44
2013 Day KE, Beck LN, Heath CH, Huang CC, Zinn KR, Rosenthal EL. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biology & Therapy. 14: 271-7. PMID 23298904 DOI: 10.4161/cbt.23300  0.44
2013 Saini R, Sorace AG, Warram JM, Mahoney MJ, Zinn KR, Hoyt K. An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound in Medicine & Biology. 39: 172-80. PMID 23122640 DOI: 10.1016/j.ultrasmedbio.2012.08.016  0.44
2012 Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Annals of Surgical Oncology. 19: 3879-87. PMID 22669455 DOI: 10.1245/s10434-012-2435-y  0.44
2012 Warram JM, Sorace AG, Saini R, Borovjagin AV, Hoyt K, Zinn KR. Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles. Cancer Gene Therapy. 19: 545-52. PMID 22653385 DOI: 10.1038/cgt.2012.29  0.44
2012 Kim KH, Dmitriev I, O'Malley JP, Wang M, Saddekni S, You Z, Preuss MA, Harris RD, Aurigemma R, Siegal GP, Zinn KR, Curiel DT, Alvarez RD. A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3440-51. PMID 22510347 DOI: 10.1158/1078-0432.CCR-11-2852  0.44
2012 Kim H, Zhai G, Samuel SL, Rigell CJ, Umphrey HR, Rana S, Stockard CR, Fineberg NS, Zinn KR. Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. Molecular Cancer Therapeutics. 11: 405-15. PMID 22203731 DOI: 10.1158/1535-7163.MCT-11-0581  0.44
2012 Oliver PG, LoBuglio AF, Zhou T, Forero A, Kim H, Zinn KR, Zhai G, Li Y, Lee CH, Buchsbaum DJ. Effect of anti-DR5 and chemotherapy on basal-like breast cancer. Breast Cancer Research and Treatment. 133: 417-26. PMID 21901385 DOI: 10.1007/s10549-011-1755-0  0.44
2012 Shah N, Zhai G, Knowles JA, Stockard CR, Grizzle WE, Fineberg N, Zhou T, Zinn KR, Rosenthal EL, Kim H. (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 237-44. PMID 21494920 DOI: 10.1007/s11307-011-0491-5  0.44
2011 Jiang J, Wan Y, Wang X, Xu J, Harris JM, Lobie PE, Zhang Y, Zinn KR, Waters MJ, Frank SJ. Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping. Endocrinology. 152: 4777-88. PMID 21990310 DOI: 10.1210/en.2011-1336  0.44
2011 Kim H, Zhai G, Liu Z, Samuel S, Shah N, Helman EE, Knowles JA, Stockard CR, Fineberg NS, Grizzle WE, Zhou T, Zinn KR, Rosenthal EL. Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anti-Cancer Drugs. 22: 864-74. PMID 21730821 DOI: 10.1097/CAD.0b013e328349311e  0.44
2011 Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 30: 921-31. PMID 21705725  0.44
2011 Saini R, Warram JM, Sorace AG, Umphrey H, Zinn KR, Hoyt K. Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. Ultrasound in Medicine & Biology. 37: 1306-13. PMID 21683507 DOI: 10.1016/j.ultrasmedbio.2011.05.010  0.44
2011 Kim H, Folks KD, Guo L, Sellers JC, Fineberg NS, Stockard CR, Grizzle WE, Buchsbaum DJ, Morgan DE, George JF, Zinn KR. Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Molecular Imaging. 10: 153-67. PMID 21496446 DOI: 10.2310/7290.2010.00040  0.44
2011 Turk AN, Byer SJ, Zinn KR, Carroll SL. Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents. Journal of Visualized Experiments : Jove. PMID 21460792 DOI: 10.3791/2558  0.44
2011 Zinn KR, Anderson CJ, Bradbury M, Cutler CS, Peterson TE, Morgan DE, Price JC, Graham MM, Contag CH, Wittstrom K, Norenberg JP. Components of a curriculum for molecular imaging scientists. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 650-6. PMID 21421709 DOI: 10.2967/jnumed.110.087064  0.44
2011 Byer SJ, Eckert JM, Brossier NM, Clodfelder-Miller BJ, Turk AN, Carroll AJ, Kappes JC, Zinn KR, Prasain JK, Carroll SL. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro-Oncology. 13: 28-41. PMID 21075781 DOI: 10.1093/neuonc/noq146  0.44
2011 Warram JM, Borovjagin AV, Zinn KR. A genetic strategy for combined screening and localized imaging of breast cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 452-61. PMID 20658194 DOI: 10.1007/s11307-010-0377-y  0.44
2011 Kim H, Folks KD, Guo L, Stockard CR, Fineberg NS, Grizzle WE, George JF, Buchsbaum DJ, Morgan DE, Zinn KR. DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 94-103. PMID 20383593 DOI: 10.1007/s11307-010-0320-2  0.44
2010 Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, Agarwal A, Zinn KR, Murphy MP, Kalyanaraman B, Darley-Usmar V. Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. The Biochemical Journal. 432: 9-19. PMID 20825366 DOI: 10.1042/BJ20100308  0.44
2010 Kim H, Chen J, Zinn KR, Hubbard WJ, Fineberg NS, Chaudry IH. Single photon emission computed tomography demonstrated efficacy of 17β-estradiol therapy in male rats after trauma-hemorrhage and extended hypotension. The Journal of Trauma. 69: 1266-73. PMID 20571453 DOI: 10.1097/TA.0b013e3181dbb0b2  0.44
2010 Helman EE, Newman JR, Dean NR, Zhang W, Zinn KR, Rosenthal EL. Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biology & Therapy. 10: 166-71. PMID 20505368  0.44
2010 Hoyt K, Warram JM, Umphrey H, Belt L, Lockhart ME, Robbin ML, Zinn KR. Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 29: 577-85. PMID 20375376  0.44
2010 Borovjagin AV, McNally LR, Wang M, Curiel DT, MacDougall MJ, Zinn KR. Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Molecular Imaging. 9: 59-75. PMID 20236604 DOI: 10.2310/7290.2010.00003  0.44
2010 Gan Y, Zhang Y, Digirolamo DJ, Jiang J, Wang X, Cao X, Zinn KR, Carbone DP, Clemens TL, Frank SJ. Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Molecular Endocrinology (Baltimore, Md.). 24: 644-56. PMID 20133448 DOI: 10.1210/me.2009-0357  0.44
2009 Kimball KJ, Rivera AA, Zinn KR, Icyuz M, Saini V, Li J, Zhu ZB, Siegal GP, Douglas JT, Curiel DT, Alvarez RD, Borovjagin AV. Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer. Molecular Imaging. 8: 264-77. PMID 19796604 DOI: 10.2310/7290.2009.00025  0.44
2009 Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis. Cancer Biology & Therapy. 8: 1109-16. PMID 19652526  0.44
2009 Chewning JH, Dugger KJ, Chaudhuri TR, Zinn KR, Weaver CT. Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model. Bmc Immunology. 10: 44. PMID 19650922 DOI: 10.1186/1471-2172-10-44  0.44
2009 Wohler JE, Smith SS, Zinn KR, Bullard DC, Barnum SR. Gammadelta T cells in EAE: early trafficking events and cytokine requirements. European Journal of Immunology. 39: 1516-26. PMID 19384874 DOI: 10.1002/eji.200839176  0.44
2009 Kashentseva EA, Douglas JT, Zinn KR, Curiel DT, Dmitriev IP. Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody. Journal of Molecular Biology. 388: 443-61. PMID 19285990 DOI: 10.1016/j.jmb.2009.03.016  0.44
2009 Dugger KJ, Zinn KR, Weaver C, Bullard DC, Barnum SR. Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 206: 22-7. PMID 19010554 DOI: 10.1016/j.jneuroim.2008.10.006  0.44
2008 Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Research. 68: 8369-76. PMID 18922909 DOI: 10.1158/0008-5472.CAN-08-1771  0.44
2008 White AF, Mazur M, Sorscher EJ, Zinn KR, Ponnazhagan S. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells. Human Gene Therapy. 19: 1407-14. PMID 18778196 DOI: 10.1089/hgt.2008.117  0.44
2008 Kim H, Morgan DE, Zeng H, Grizzle WE, Warram JM, Stockard CR, Wang D, Zinn KR. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology. 248: 844-51. PMID 18710978 DOI: 10.1148/radiol.2483071740  0.44
2008 Newman JR, Gleysteen JP, Barañano CF, Bremser JR, Zhang W, Zinn KR, Rosenthal EL. Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biology & Therapy. 7: 1063-70. PMID 18431087  0.44
2008 Chanda D, Isayeva T, Kumar S, Siegal GP, Szafran AA, Zinn KR, Reddy VV, Ponnazhagan S. Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 871-8. PMID 18388919 DOI: 10.1038/mt.2008.48  0.44
2008 Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2180-9. PMID 18381960 DOI: 10.1158/1078-0432.CCR-07-1392  0.44
2008 Wang X, Jiang J, Warram J, Baumann G, Gan Y, Menon RK, Denson LA, Zinn KR, Frank SJ. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Molecular Endocrinology (Baltimore, Md.). 22: 1427-37. PMID 18323468 DOI: 10.1210/me.2007-0561  0.44
2008 Gleysteen JP, Newman JR, Chhieng D, Frost A, Zinn KR, Rosenthal EL. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head & Neck. 30: 782-9. PMID 18228526 DOI: 10.1002/hed.20782  0.44
2008 Zinn KR, Chaudhuri TR, Szafran AA, O'Quinn D, Weaver C, Dugger K, Lamar D, Kesterson RA, Wang X, Frank SJ. Noninvasive bioluminescence imaging in small animals. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 49: 103-15. PMID 18172337  0.44
2007 Derosier LC, Vickers SM, Zinn KR, Huang Z, Wang W, Grizzle WE, Sellers J, Stockard CR, Zhou T, Oliver PG, Arnoletti P, Lobuglio AF, Buchsbaum DJ. TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth. Molecular Cancer Therapeutics. 6: 3198-207. PMID 18089714 DOI: 10.1158/1535-7163.MCT-07-0299  0.44
2007 Wang L, Martin DR, Baker HJ, Zinn KR, Kappes JC, Ding H, Gentry AS, Harper S, Snyder EY, Cox NR. Neural progenitor cell transplantation and imaging in a large animal model. Neuroscience Research. 59: 327-40. PMID 17897743 DOI: 10.1016/j.neures.2007.08.011  0.44
2007 DeRosier LC, Buchsbaum DJ, Oliver PG, Huang ZQ, Sellers JC, Grizzle WE, Wang W, Zhou T, Zinn KR, Long JW, Vickers SM. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5535s-5543s. PMID 17875786 DOI: 10.1158/1078-0432.CCR-07-1075  0.44
2007 Roberts J, Chen B, Curtis LM, Agarwal A, Sanders PW, Zinn KR. Detection of early changes in renal function using 99mTc-MAG3 imaging in a murine model of ischemia-reperfusion injury. American Journal of Physiology. Renal Physiology. 293: F1408-12. PMID 17634403 DOI: 10.1152/ajprenal.00083.2007  0.44
2007 Cowey S, Szafran AA, Kappes J, Zinn KR, Siegal GP, Desmond RA, Kim H, Evans L, Hardy RW. Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clinical & Experimental Metastasis. 24: 389-401. PMID 17541709 DOI: 10.1007/s10585-007-9076-8  0.44
2007 Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Molecular Cancer Therapeutics. 6: 1230-8. PMID 17431103 DOI: 10.1158/1535-7163.MCT-06-0741  0.44
2007 Kim H, Chaudhuri TR, Buchsbaum DJ, Wang D, Zinn KR. High-resolution single-photon emission computed tomography and X-ray computed tomography imaging of Tc-99m-labeled anti-DR5 antibody in breast tumor xenografts. Molecular Cancer Therapeutics. 6: 866-75. PMID 17363481 DOI: 10.1158/1535-7163.MCT-06-0230  0.44
2007 Oh P, Borgström P, Witkiewicz H, Li Y, Borgström BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nature Biotechnology. 25: 327-37. PMID 17334358 DOI: 10.1038/nbt1292  0.44
2007 Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood. 109: 4336-42. PMID 17244679 DOI: 10.1182/blood-2006-09-046201  0.44
2006 He X, Schoeb TR, Panoskaltsis-Mortari A, Zinn KR, Kesterson RA, Zhang J, Samuel S, Hicks MJ, Hickey MJ, Bullard DC. Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. Journal of Immunology (Baltimore, Md. : 1950). 177: 8748-56. PMID 17142777  0.44
2006 Frank SJ, Wang X, He K, Yang N, Fang P, Rosenfeld RG, Hwa V, Chaudhuri TR, Deng L, Zinn KR. In vivo imaging of hepatic growth hormone signaling. Molecular Endocrinology (Baltimore, Md.). 20: 2819-30. PMID 16803867 DOI: 10.1210/me.2005-0532  0.44
2005 Buchsbaum DJ, Khazaeli MB, Axworthy DB, Schultz J, Chaudhuri TR, Zinn KR, Carpenter M, LoBuglio AF. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8180-5. PMID 16299250 DOI: 10.1158/1078-0432.CCR-05-0607  0.44
2005 Buchsbaum DJ, Chaudhuri TR, Zinn KR. Radiotargeted gene therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 179S-86S. PMID 15653667  0.44
2004 Buchsbaum DJ, Chaudhuri TR, Yamamoto M, Zinn KR. Gene expression imaging with radiolabeled peptides. Annals of Nuclear Medicine. 18: 275-83. PMID 15359919  0.44
2003 Zinn KR, Rodríguez-Burford C, Chaudhuri TR. Sinusoidal endothelium in mouse liver show rapid and saturable binding of Jo2 anti-Fas antibody. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 326-36. PMID 14630512 DOI: 10.1016/j.mibio.2003.09.005  0.44
2003 Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang M, Liu B, Cao Z, Alvarez RD, Curiel DT, Hemminki A. Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 449-58. PMID 12946318 DOI: 10.1016/S1525-0016(03)00200-4  0.44
2003 Xu Y, Szalai AJ, Zhou T, Zinn KR, Chaudhuri TR, Li X, Koopman WJ, Kimberly RP. Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics. Journal of Immunology (Baltimore, Md. : 1950). 171: 562-8. PMID 12847219  0.44
2003 Chaudhuri TR, Cao Z, Krasnykh VN, Stargel AV, Belousova N, Partridge EE, Zinn KR. Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts. Technology in Cancer Research & Treatment. 2: 171-80. PMID 12680799  0.44
2003 Jiao J, Greendorfer JS, Zhang P, Zinn KR, Diglio CA, Thompson JA. Alternatively spliced FGFR-1 isoform signaling differentially modulates endothelial cell responses to peroxynitrite. Archives of Biochemistry and Biophysics. 410: 187-200. PMID 12573278 DOI: 10.1016/S0003-9861(02)00681-1  0.44
2002 Zaliauskiene L, Fazio RL, Kang S, Sparks K, Weaver CT, Zinn KR, Collawn JF. Inhibition of T cell responses by transferrin-coupled competitor peptides. Immunologic Research. 26: 77-85. PMID 12403347 DOI: 10.1385/IR:26:1-3:077  0.44
2002 Zaliauskiene L, Kang S, Sparks K, Zinn KR, Schwiebert LM, Weaver CT, Collawn JF. Enhancement of MHC class II-restricted responses by receptor-mediated uptake of peptide antigens. Journal of Immunology (Baltimore, Md. : 1950). 169: 2337-45. PMID 12193699  0.44
2002 Chaudhuri TR, Cao Z, Rodríguez-Burford C, LoBuglio AF, Zinn KR. A non-invasive approach for monitoring breast tumor cells during therapeutic intervention. Cancer Biotherapy & Radiopharmaceuticals. 17: 205-12. PMID 12030114 DOI: 10.1089/108497802753773829  0.44
2002 Zinn KR, Kelpke S, Akhi K, Viera L, Chaudhuri TR, Thompson JA. Glomerular targeting of acidic fibroblast growth factor-1 in renal transplanted rats. Transplantation. 73: 1447-54. PMID 12023623  0.44
2002 Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes MN, Alvarez RD, Curiel DT. In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. Journal of the National Cancer Institute. 94: 741-9. PMID 12011224  0.44
2002 Zinn KR, Chaudhuri TR. The type 2 human somatostatin receptor as a platform for reporter gene imaging. European Journal of Nuclear Medicine and Molecular Imaging. 29: 388-99. PMID 12002716 DOI: 10.1007/s00259-002-0764-y  0.44
2002 Zinn KR, Chaudhuri TR, Krasnykh VN, Buchsbaum DJ, Belousova N, Grizzle WE, Curiel DT, Rogers BE. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology. 223: 417-25. PMID 11997547 DOI: 10.1148/radiol.2232010501  0.44
2002 Rogers BE, Zinn KR, Lin CY, Chaudhuri TR, Buchsbaum DJ. Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector. Cancer. 94: 1298-305. PMID 11877760 DOI: 10.1002/cncr.10300  0.44
Show low-probability matches.